Leadart Biotechnologies, Inc.

LeadArt is thrilled to co-organize the 1st Global Digital Intelligence Education Innovation Competition! 🎉 Join us for the Life Science Track: Natural Product Protein Target Binding Prediction Challenge. This competition is a fantastic opportunity for innovators and researchers to showcase their skills in digital intelligence and life sciences. 🔬 Dive into the world of natural product protein target binding prediction and push the boundaries of scientific discovery. 🔗 Learn more and register here: https://lnkd.in/ghq_BbTc Let's drive innovation together! 💡🌍 #LeadArt #DigitalIntelligence #EducationInnovation #LifeScience #NaturalProduct #ProteinTarget #InnovationChallenge #ScientificDiscovery

Large-scale #Chemoproteomics data bridge the gap in data-driven drug discovery. Live cell #Chemoproteomics ligand screening assays bridge the gap in traditional compound screening methods. 🚀 Looking forward to connecting with potential collaborators at #BIO San Diego from June 3-6, 2024. Let’s innovate together!

The “Target Space Station” enables large-scale drug-target binding datasets collection. Currently, 20,000+ chemoproteomics samples can be prepared per year. #chemoproteomics #automation #biodata Leadart Biotechnologies, Inc.

The role of #large-#scale #chemoproteomics databases in advancing drug discovery is pivotal. A recent #Science publication showcases Pfizer's strategic foresight, featuring the collection of chemoproteomics datasets from 400 #photoaffinity ligands. At Leadart Biotechnologies, Inc., we are leading the way in #Automated #Chemoproteomics for #DrugDiscovery. Our state-of-the-art automated sample preparation system allows us to efficiently generate over 20,000 chemoproteomics datasets annually. Discover how we are shaping the future of drug discovery with our innovative approaches on www.leadartech.com. https://lnkd.in/dd9Tvs8T

Exciting news! We'll be at the #BIO one-on-one partnering events in San Diego from June 3-6, 2024. Feng Ni and Jie Yan from LeadArt Biotechnologies, Inc. are eager to explore #collaboration and #partnership opportunities with leaders in the #Pharma and #Biotech industries. 🌟 Why LeadArt Biotechnologies? We're at the forefront of #automated #Chemoproteomics in drug discovery: 1, #Propartitary #Probe #Library: Our unique probe library includes over 4,000 photoactive probes and more than 300 ABPP probes, capable of labeling over 14,000 human proteins. 2, #Automated #Sample #Prep: We've developed the first automated chemoproteomics sample preparation system, improving efficiency by 100x over manual methods. This system supports #large-scale collection of #protein-drug #binding #datasets with high-quality data at lower costs. 3, #INTRAP #HTS #Platform: Our #livecell-based #screening platform, #INTRAP, is designed for targets that are difficult to address with traditional #HTS and #DEL screening methods. Looking forward to meaningful discussions and potential partnerships. See you in #SanDiego!

Our newest bi-lingual website is www.leadartech.com